Zfp781 Inhibitors
Zfp781, a zinc finger protein, plays a crucial role in cellular processes. It is involved in the intricate regulation of gene expression and modulation of cellular pathways. The primary function of Zfp781 centers around its capacity to act as a transcriptional regulator, influencing the expression of genes involved in key cellular activities.
Inhibition of Zfp781 can be achieved through diverse chemical entities targeting specific pathways associated with its function. The identified inhibitors disrupt crucial signaling cascades, such as PI3K/Akt, MAPK, and JNK, either directly or indirectly, impacting Zfp781 expression and function. For instance, compounds like GSK 690693 directly inhibit Akt, a downstream target influencing Zfp781, while others like SB 203580 indirectly inhibit Zfp781 by disrupting the p38 MAPK pathway. Understanding the specific pathways influenced by each inhibitor is vital for unraveling the intricate network of interactions that regulate Zfp781. This detailed insight into the biochemical and cellular processes affected by these inhibitors provides a foundation for further exploration of targeted modulation of Zfp781 in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
GSK 690693, a selective Akt inhibitor, hinders Zfp781 by disrupting the PI3K/Akt signaling pathway. Akt, a downstream target, influences Zfp781 expression and function, inhibiting its role in cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 acts as a potent inhibitor of p38 MAPK, indirectly inhibiting Zfp781. By disrupting the p38 MAPK pathway, it affects downstream elements that modulate Zfp781 expression, leading to its inhibition. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a multi-kinase inhibitor, influences the Raf/MEK/ERK pathway. Through this modulation, Zfp781 is indirectly inhibited, as its activity is intertwined with the cascades affected by Sorafenib. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, directly disrupts the PI3K/Akt pathway, impeding Zfp781 expression and function. This direct inhibition is attributed to the crucial role of PI3K/Akt in regulating Zfp781 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 interferes with the JNK pathway, indirectly inhibiting Zfp781. The disruption of this pathway leads to alterations in Zfp781 expression and function, resulting in its inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, directly impacts the MAPK pathway, influencing Zfp781. Through this direct inhibition, U0126 disrupts the cascades that regulate Zfp781, leading to its inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, indirectly affecting Zfp781. The mTOR pathway intersects with Zfp781 modulation, leading to its indirect inhibition when exposed to Rapamycin. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, directly hampers the PI3K/Akt pathway, impacting Zfp781 expression and function. The direct inhibition of PI3K/Akt by Wortmannin leads to the inhibition of Zfp781. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, a selective MEK inhibitor, directly influences the MAPK pathway, affecting Zfp781. The inhibition of MEK alters the cascades regulating Zfp781 expression and function, resulting in its inhibition. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363, an Akt inhibitor, directly affects the PI3K/Akt pathway, leading to the inhibition of Zfp781. The disruption of Akt activity modulates Zfp781 expression and function, resulting in its inhibition. | ||||||